Industry12h ago
FDA Pilots AI For Real Time Trial Monitoring
The FDA is launching a pilot program using AI and cloud computing to monitor clinical trials in real time. This shift aims to shorten drug approval timelines. The move follows staffing losses from DOGE layoffs. Practitioners can expect faster regulatory feedback loops and more digitized oversight of trial data.